Skip to main content

Publications

Found 181 results
[ Author(Desc)] Title Year
Filters: Filter is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Katageri G, Charantimath U, Joshi A, Vidler M, Ramadurg U, Sharma S, et al.. Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India. Reproductive Health [Internet]. 2018;15(S1). https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-018-0531-6http://link.springer.com/content/pdf/10.1186/s12978-018-0531-6.pdf (460.75 KB)
von Dadelszen P, Flint-O’Kane M, Poston L, Craik R, Russell D, Tribe RM, et al.. The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) Network’s first protocol: deep phenotyping in three sub-Saharan African countries. Reproductive Health. 2020;17(S1).  (1.89 MB)
Magee LA, Strang A, Li L, Tu D, Tumtaweetikul W, Craik R, et al.. The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) database: open-access data collection in maternal and newborn health. Reproductive Health. 2020;17(S1).  (1.21 MB)
Craik R, Russell D, Tribe RM, Poston L, Omuse G, Okiro P, et al.. PRECISE pregnancy cohort: challenges and strategies in setting up a biorepository in sub-Saharan Africa. Reproductive Health. 2020;17(S1).  (633.9 KB)
Daniele MAS, Martinez-Alvarez M, Etyang AKoech, Vidler M, Salisbury T, Makanga PTatenda, et al.. The contribution of qualitative research within the PRECISE study in sub-Saharan Africa. Reproductive Health. 2020;17(S1).  (507.25 KB)
Flint-O’Kane M, von Dadelszen P, Makanga PTatenda, Sevene E, Roca A, Dukes P, et al.. Harnessing the PRECISE network as a platform to strengthen global capacity for maternal and child health research in sub-Saharan Africa. Reproductive Health. 2020;17(S1).  (1.12 MB)
Thornton C, Tooher J, Ogle R, von Dadelszen P, Makris A, Hennessy A. Benchmarking the Hypertensive Disorders of Pregnancy. Pregnancy Hypertens. 2016;6(4):279-284.  (294.88 KB)
Tsigas E. Advocacy is essential to supporting women with pre-eclampsia. Obstet Med. 2017;10(1):33-35.  (85.27 KB)
Tsigas E, Magee LA. Advocacy organisations as partners in pre-eclampsia progress: patient involvement improves outcomes. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):523-36.  (438.09 KB)
U
Ukah V, De Silva D, Payne BA, Magee LA, Hutcheon J, Brown H, et al.. Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertens. 2018;11:115-123.  (501.41 KB)
Ukah V, Mbofana F, Rocha B, Loquiha O, Mudenyanga C, Usta M, et al.. Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique. Hypertension. 2017;69(3):469-474.  (378.99 KB)
Ukah V, Payne BA, Karjalainen H, Kortelainen E, Seed P, Conti-Ramsden FInez, et al.. Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia. Pregnancy Hypertens. 2019;15:42-50.  (887.01 KB)
Ukah V, Payne BA, Lee T, Magee LA, von Dadelszen P. External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries. Hypertension. 2017;69(4):705-711.  (149.83 KB)
Ukah V, Payne BA, Hutcheon J, Ansermino JM, Ganzevoort J, Thangaratinam S, et al.. Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018;71(4):659-665.  (237.99 KB)
Ukah V. THE fullPIERS RISK PREDICTION MODEL FOR WOMEN WITH PRE-ECLAMPSIA: EXTERNAL VALIDATION, RECALIBRATION AND ADDED VALUE OF A NOVEL BIOMARKER (PLACENTAL GROWTH FACTOR). In 2017.  (2.49 MB)
Ukah V, Hutcheon J, Payne BA, Haslam M, Vatish M, Ansermino JM, et al.. Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review. Hypertension. 2017;70(6):1228-1237.  (986.49 KB)
Ukah V, Adu PA, De Silva D, von Dadelszen P. The Impact of a History of Adverse Childhood Experiences on Breastfeeding Initiation and Exclusivity: Findings from a National Population Health Survey. Breastfeed Med. 2016;11:544-550.  (199.72 KB)
V
Vaiman D. Genes, epigenetics and miRNA regulation in the placenta. Placenta. 2017;52:127-133.  (495.08 KB)
Velicky P, Windsperger K, Petroczi K, Pils S, Reiter B, Weiss T, et al.. Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia. Sci Rep. 2018;8(1):6342.  (3.16 MB)
Vidler M, Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, et al.. Women's views and postpartum follow-up in the CHIPS Trial (Control of Hypertension in Pregnancy Study). Eur J Obstet Gynecol Reprod Biol. 2016;206:105-113.  (412.73 KB)
Vidler M, Ramadurg U, Charanthimath U, Katageri G, Karadiguddi C, Sawchuck D, et al.. Utilization of maternal health care services and their determinants in Karnataka State, India. Reprod Health. 2016;13 Suppl 1:37.  (941.52 KB)
Vidler M, Charanthimath U, Katageri G, Ramadurg U, Karadiguddi C, Sawchuck D, et al.. Community perceptions of pre-eclampsia in rural Karnataka State, India: a qualitative study. Reprod Health. 2016;13 Suppl 1:35.  (810.48 KB)
von Dadelszen P, Khalil A, Wolfe I, Kametas NA, O’Brien P, Magee LA. “Women and children last”—effects of the covid-19 pandemic on reproductive, perinatal, and paediatric health. BMJ [Internet]. 2020;:m2287. http://www.bmj.com/lookup/doi/10.1136/bmj.m2287https://syndication.highwire.org/content/doi/10.1136/bmj.m2287http://data.bmj.org/tdm/10.1136/bmj.m2287 (167.42 KB)
von Dadelszen P, Magee LA. Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;36:83-102.  (389.82 KB)
von Dadelszen P, Magee LA, Payne BA, Dunsmuir D, Drebit S, Dumont G, et al.. Moving beyond silos: How do we provide distributed personalized medicine to pregnant women everywhere at scale? Insights from PRE-EMPT. Int J Gynaecol Obstet. 2015;131 Suppl 1:S10-5.  (662.6 KB)
von Dadelszen P, Firoz T, Donnay F, Gordon R, Hofmeyr J, Lalani S, et al.. Preeclampsia in low and middle income countries-health services lessons learned from the PRE-EMPT (PRE-Eclampsia-Eclampsia Monitoring, Prevention and Treatment) project. J Obstet Gynaecol Can. 2012;34(10):917-926.  (322.96 KB)
von Dadelszen P, Magee LA. Pre-eclampsia: an update. Curr Hypertens Rep. 2014;16(8):454.  (486.35 KB)
von Dadelszen P, Sawchuck D, Hofmeyr J, Magee LA, Bracken H, Mathai M, et al.. PRE-EMPT (PRE-eclampsia-Eclampsia Monitoring, Prevention and Treatment): A low and middle income country initiative to reduce the global burden of maternal, fetal and infant death and disease related to pre-eclampsia. Pregnancy Hypertens. 2013;3(4):199-202.  (183.96 KB)
von Dadelszen P, Payne BA, Li J, Ansermino JM, F Pipkin B, Côté A-M, et al.. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377(9761):219-27.  (201.46 KB)
von Dadelszen P, Ansermino JM, Dumont G, Hofmeyr J, Magee LA, Mathai M, et al.. Improving maternal and perinatal outcomes in the hypertensive disorders of pregnancy: A vision of a community-focused approach. Int J Gynaecol Obstet. 2012;119 Suppl 1:S30-S34.  (112.74 KB)

Pages